Trademark Overview
On Friday, June 6, 2025, a trademark application was filed for ANTHARIS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ANTHARIS THERAPEUTICS trademark a serial number of 99222134. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 6, 2025. This trademark is owned by Antharis Therapeutics Holdings Inc.. The ANTHARIS THERAPEUTICS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Custom manufacturing of therapeutic agents for use in pharmaceuticals
Biologics in the nature of pharmaceutical preparations; Pharmaceutical and biological preparations for use in oncology, immunology, and immuno-oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing tumors, cancer, and inflammatory disorders; Therapeutic agents for medical use, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and engineered antibodies for increasing T-cell activation, increasing phagocytosis, reducing cytokine release, and suppressing over expressing tumors and cancer cells
Research and development in the fields of immune-oncology, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology; Providing medical research information in the fields of monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology